Profil
Lida Pacaud is currently Chief Executive & Medical Officer at Ichnos Glenmark Innovation, Inc. starting in 2025.
Formerly, Dr. Pacaud was Vice President-Clinical Development at Legend Biotech Corp.
from 2021 to 2023 and Head-Global Clinical Program at Novartis International AG from 2013 to 2021.
Education includes a doctorate from Tbilisi State Medical University.
Postes actifs de Lida Pacaud
| Sociétés | Poste | Début |
|---|---|---|
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Directeur Général | 06/12/2025 |
Anciens postes connus de Lida Pacaud
| Sociétés | Poste | Fin |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Directeur Technique/Scientifique/R&D | 01/06/2023 |
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Corporate Officer/Principal | 01/01/2021 |
Formation de Lida Pacaud
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Novartis International AG
Novartis International AG Pharmaceuticals: MajorHealth Technology Offers healthcare solutions | Health Technology |
Legend Biotech Corp.
Legend Biotech Corp. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which engages in the discovery and development of novel cell therapies for oncology | Health Technology |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops biologics in oncology | Health Technology |
Tbilisi State Medical University
Tbilisi State Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















